A low-cost antibiotic which has performed well in tests should be given to all HIV children in developing countries to prevent infections such as pneumonia and reduce deaths, scientists said on Friday. Dr. Diana Gibb of Britain’s Medical Research Council said a trial involving HIV-infected children in Zambia was stopped early because it was so successful. A daily dose of the drug co-trimoxazole nearly halved the death rate in youngsters taking it compared to those given a placebo.
